Grant of options

CAP-XX Limited
14 August 2024
 

14 August 2024

CAP-XX Limited

("CAP-XX" or "the Company")

Grant of options

Further to the Company's announcement on 18 June 2024, the Board of CAP-XX, a world leader in the design and manufacture of supercapacitors and energy management systems, announces that the Company has granted 60,000,000 options (the "Options") over ordinary shares of no par value in the Company ("Ordinary Shares") to certain employees.

The exercise price of the Options is 0.08p, as was announced on 18 June 2024, being the closing mid-market price of an Ordinary Share on 17 June 2024, the last practicable date prior to the proposed grant of the Options. The Options vest annually in equal instalments over five years.

Following this grant of Options, the total number of options outstanding over Ordinary Shares in the Company will be 224,165,000.

For further information contact:

CAP-XX Limited

Pat Elliott (Chairman)                                                                             +61 (2) 9157 0000

Lars Stegmann (Chief Executive Officer)

 

Allenby Capital (Nominated Adviser and Broker)

David Hart / Piers Shimwell (Corporate Finance)                                      +44 (0) 20 3328 5656

Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)

 

Notes to Editors:

CAP-XX (LSE: CPX) is a leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high-power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics and deliver similar benefits in automotive and other transportation applications.

For more information about CAP-XX, visit www.cap-xx.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings